The Effect of Cataract on Photoentrainment of the Circadian Rhythm in Humans

NCT ID: NCT01686308

Last Updated: 2015-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-28

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cataract is globally the most common cause of blindness and in Denmark the operation with - 50.000 treatments per year - is the most common eye operation. The cause of cataract is growth and denaturation of the lens proteins. This leads to an increased absorption of blue light and increased light scatter. This may affect newly discovered cells in the retina that are involved in the regulation of the circadian rhythm. When the internal circadian rhythm is not synchronized with the external day and night a phase-shift occurs. Most people know of this discomfort as jet-lag, but the consequences may be much more severe such as heighten risk of cancer and cardiovascular disease.

The goal of this project is to study how the circadian regulating cells of the retina is affected by cataract and by the operation. Cataract patients are studied before and after the operation with questionnaires, hormone and activity measurements and with a specialized pupil measurement that measures the indirect response of the circadian regulating cells to blue light.

Results from this study aim to shed light on the regulatory mechanisms of the eye on the circadian rhythm and how these are affected by cataract. Furthermore, choice of intraocular lens is evaluated. This may have impact on clinical practise especially with regard to choice of intraocular lens and widened indications for cataract surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional Intra Ocular Lens (IOL)

Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.

Group Type ACTIVE_COMPARATOR

Conventional Intra Ocular Lens (IOL)

Intervention Type PROCEDURE

Standard operation with conventional IOL implantation

Yellow Intra Ocular Lens (IOL)

Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.

Group Type EXPERIMENTAL

Yellow Intra Ocular Lens (IOL)

Intervention Type PROCEDURE

Standard operation with blue light filter Yellow IOL implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Yellow Intra Ocular Lens (IOL)

Standard operation with blue light filter Yellow IOL implantation

Intervention Type PROCEDURE

Conventional Intra Ocular Lens (IOL)

Standard operation with conventional IOL implantation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age related/senile bilateral cataract
* Eligible for phaco-emulsification on both eyes

Exclusion Criteria

* Known eye disease other than cataract.
* Known systemic disease, which may affect the retina (untreated hypertension, DM etc.)
* Known systemic disease, which may affect the lens.
* Known psychiatric disease.
* Known sleep or circadian rhythm disorder, not caused by lowered blue light transmission by the lens.
* Per- and post operative complications
* Use of drugs that may affect the sleep.

For a subpopulation also:

* Poor cooperation.
* Severe refraction abnormalities.
* Previous eye surgery
* Nystagmus
* Congenital or acquired abnormalities of: eye lids and eye area, cornea or iris.
* Use of medicine that may affect the pupillary response.
* Use of drugs that may affect the pupillary response.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Glostrup University Hospital, Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Adam Elias Brøndsted

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adam E Brøndsted, MD

Role: PRINCIPAL_INVESTIGATOR

Glostrup UH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Glostrup University Hospital

Glostrup Municipality, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIRCAT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.